Azido-PEG1-azide

CAS No. 24345-74-2

Azido-PEG1-azide( —— )

Catalog No. M24118 CAS No. 24345-74-2

Azido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 28 In Stock
25MG 29 In Stock
50MG 38 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Azido-PEG1-azide
  • Note
    Research use only, not for human use.
  • Brief Description
    Azido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    Azido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs
  • In Vitro
    PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PROTACs
  • Target
    PROTAC
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    24345-74-2
  • Formula Weight
    156.15
  • Molecular Formula
    C4H8N6O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [N-]=[N+]=NCCOCCN=[N+]=[N-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
  • 6-Maleimidocapronic ...

    6-Maleimidocapronic acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.

  • FKBP12 PROTAC dTAG-1...

    FKBP12 PROTAC dTAG-13 (dTAG-13) is an in vivo-active heterobifunctional adation tag (dTAG) small molecule that engage FKBP12F36V and CRBN.

  • ARV-771

    ARV-771, a small-molecule pan-BET degrader based on proteolysis-targeting chimera (PROTAC) technology, demonstrates dramatically improved efficacy in cellular models of CRPC as compared with BET inhibition.